financetom
Business
financetom
/
Business
/
Marsh McLennan beats profit estimates on risk and insurance business strength
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Marsh McLennan beats profit estimates on risk and insurance business strength
Jan 30, 2025 5:25 AM

Jan 30 (Reuters) - Insurance brokerage and consulting

company Marsh McLennan's ( MMC ) fourth-quarter profit beat Wall

Street estimates on Thursday, as its risk and insurance business

recorded strong growth.

WHY IT'S IMPORTANT

Insurers have consistently raised policy prices in recent

years in response to losses from wars and natural catastrophes,

along with inflationary pressures.

The sector usually sees steady or even heightened demand

during economic uncertainty. Strong demand trends in the broader

industry have also boosted income for brokerages like Marsh &

McLennan ( MMC ), which earn commissions based on insurance premiums.

BY THE NUMBERS

On an adjusted basis, the New York-based firm earned $927

million for the quarter ended Dec. 31, or $1.87 per share.

Analysts on average were expecting $1.76 per share,

according to data compiled by LSEG.

It reported a total revenue of $6.07 billion in the quarter,

up 9.2% from last year.

Marsh McLennan's ( MMC ) risk and insurance services business posted

revenue growth of 11.5%, while its consulting arm's revenue

climbed 6.1%.

Its fiduciary interest income - earnings on funds held on

behalf of clients - fell 9% to $112 million.

CONTEXT

Marsh McLennan ( MMC ), through its four subsidiaries - Marsh,

Mercer, Oliver Wyman, and Guy Carpenter - provides risk,

insurance, and consulting services in over 130 countries.

The company went on a $10 billion acquisition spree in 2024,

including the $7.75 billion purchase of McGriff, completed in

November.

Earlier this week, insurance brokerage Brown & Brown ( BRO )

also beat fourth-quarter profit estimates, driven by robust

growth in investment returns and increased commissions and fees.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sonoro Gold Closes C$15.5 Million Private Placement
Sonoro Gold Closes C$15.5 Million Private Placement
Jun 10, 2026
09:30 AM EDT, 06/10/2026 (MT Newswires) -- Sonoro Gold ( SMOFF ) raised C$15.5 million after closing a private placement of 62 million units priced at $0.25 per unit, the company said Wednesday. Sonoro plans to use the proceeds for general working capital purposes. The company is advancing the Cerro Caliche gold project in Mexico, where it recently commenced a...
AutoCanada Completes Acquisition of Mascarin Collision Centre
AutoCanada Completes Acquisition of Mascarin Collision Centre
Jun 10, 2026
09:33 AM EDT, 06/10/2026 (MT Newswires) -- AutoCanada ( AOCIF ) on Wednesday announced the completion of its acquisition of Mascarin Collision Centre, a collision repair business based in Thunder Bay, Ontario. The business holds OEM certifications across more than 10 brands, including Volkswagen, Honda, Toyota, Ford, General Motors, and Subaru, said the company, and added that Mascarin is the...
Micron Technology Selects Bechtel as Construction Partner for New York Semiconductor Manufacturing Facility
Micron Technology Selects Bechtel as Construction Partner for New York Semiconductor Manufacturing Facility
Jun 10, 2026
09:37 AM EDT, 06/10/2026 (MT Newswires) -- Micron Technology ( MU ) has selected Bechtel as its engineering, procurement and construction partner for the first phase of its memory manufacturing complex in Clay, New York, the semiconductor company said Wednesday. Micron said it targets the complex to become the largest semiconductor manufacturing facility in the US. The company plans to...
Vivos Therapeutics Enters Collaboration With Florida Firm to Treat Cardiovascular Patients
Vivos Therapeutics Enters Collaboration With Florida Firm to Treat Cardiovascular Patients
Jun 10, 2026
09:38 AM EDT, 06/10/2026 (MT Newswires) -- Vivos Therapeutics ( VVOS ) said Wednesday it has signed a collaboration agreement with Florida-based South Palm Cardiovascular Associates to support the formation and operation of AIM Florida. AIM Florida is a management services organization that will provide diagnostic and treatment services for cardiovascular disease patients who also suffer from obstructive sleep apnea...
Copyright 2023-2026 - www.financetom.com All Rights Reserved